Vimarsana
Biggest News Aggregation in the World

Michael Raab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Raab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Raab Today - Breaking & Trending Today

BLOOMBERG Bloomberg Daybreak Europe July 12, 2024 - Vimarsana News

BLOOMBERG Bloomberg Daybreak Europe July 12, 2024

Margin. The result is seen as pivotal for the future ties of the nation with the European Union. And u. S. Banks are braced for the worth order since the quarter for the worse quarter since the financial crisis. Jp morgan kicks off a big rank week. Good morning, it is 6 00 a. M. In london. It is getting hot here. With an untamed virus irrationalional exuberance in stocks. It could get tricky. Goldman has upped their view of their earnings. Yall so have the gilead story in terms of remdesivir helping the severely ill despite the untamed virus in florida exceeding the peaks of new york and texas...

Ardelyx, Inc. (NASDAQ:ARDX) Sees Significant Decline in Short Interest - Vimarsana News

Ardelyx, Inc. (NASDAQ:ARDX) Sees Significant Decline in Short Interest

Ardelyx, Inc. (NASDAQ:ARDX – Get Free Report) was the target of a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 33,040,000 shares, a drop of 6.1% from the April 30th total of 35,170,000 shares. Based on an average daily trading volume, of 5,610,000 shares, […]

Ardelyx, Inc. (NASDAQ:ARDX) CEO Michael Raab Sells 7,500 Shares of Stock - Vimarsana News

Ardelyx, Inc. (NASDAQ:ARDX) CEO Michael Raab Sells 7,500 Shares of Stock

Ardelyx, Inc. (NASDAQ:ARDX – Get Free Report) CEO Michael Raab sold 7,500 shares of the firm’s stock in a transaction on Wednesday, May 29th. The stock was sold at an average price of $6.72, for a total transaction of $50,400.00. Following the sale, the chief executive officer now owns 1,270,273 shares in the company, valued […]

Ardelyx (NASDAQ:ARDX) Receives "Overweight" Rating from Piper Sandler - Vimarsana News

Ardelyx (NASDAQ:ARDX) Receives "Overweight" Rating from Piper Sandler

Piper Sandler reissued their overweight rating on shares of Ardelyx (NASDAQ:ARDX – Free Report) in a report released on Friday morning, Benzinga reports. The firm currently has a $15.00 target price on the biopharmaceutical company’s stock. ARDX has been the topic of a number of other research reports. SVB Leerink began coverage on shares of […]

Ardelyx (NASDAQ:ARDX) Rating Reiterated by Wedbush - Vimarsana News

Ardelyx (NASDAQ:ARDX) Rating Reiterated by Wedbush

Wedbush reissued their outperform rating on shares of Ardelyx (NASDAQ:ARDX – Free Report) in a report published on Friday, Benzinga reports. The firm currently has a $15.00 price target on the biopharmaceutical company’s stock. A number of other brokerages have also weighed in on ARDX. Citigroup increased their target price on shares of Ardelyx from […]

Source: wkrb13.com